Streetbeat News

Stock Prices

GSK

GSK shares are trading higher following the release of their mixed Q4 financial results and the issuance of future guidance.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:40 pm

HNI

RGP

SWK

The article discusses three high-yielding dividend stocks in the industrials sector recommended by Wall Street's most accurate analysts. HNI Corporation (HNI) has a dividend yield of 3.03% and received a Buy rating with a price target increase from Benchmark analyst Reuben Garner. Stanley Black & Decker, Inc. (SWK) has a dividend yield of 3.40% but was downgraded to Underweight by JP Morgan analyst Michael Rehaut. Resources Connection, Inc. (RGP) offers a dividend yield of 4.14% and maintained an Underweight rating from JP Morgan analyst Andrew Steinerman. All companies have recent news affecting their performance, with HNI and RGP reporting better-than-expected earnings, while SWK reported a sales decline.

Portfolio Pulse from Avi Kapoor

January 31, 2024 | 1:39 pm

NVO

Novo Nordisk A/S (NYSE:NVO) reported Q4 2023 sales of $9.5 billion, exceeding consensus estimates and showing a 37% increase in Danish kroner and 43% at CER year-over-year. The growth was driven by Diabetes and Obesity care, with GLP-1 diabetes sales up 62% and Obesity care sales up 114% at CER. Wegovy sales rose 293% Y/Y, while insulin and rare disease sales declined. The company has begun increasing US supply of lower dose Wegovy and plans a gradual international rollout. Novo Nordisk forecasts 18%-26% sales growth and 21%-29% operating profit growth for 2024. NVO shares rose 1.48% in premarket trading.

Portfolio Pulse from Vandana Singh

January 31, 2024 | 1:39 pm

AMSC

ENSC

PARA

Ensysce Biosciences (ENSC) reported the completion of a successful end-of-Phase 2 meeting with the FDA for its analgesic PF614, with Phase 3 enrollment starting mid-2024. Allen Media Group offered $14.3 billion to acquire Paramount Global (PARA), as reported by the Wall Street Journal. AMSC shares dropped after announcing a proposed public offering of common stock.

Portfolio Pulse from ryanfaloona@benzinga.com

January 31, 2024 | 1:36 pm

LNG

Cheniere Energy, Inc. has announced its uplisting to the New York Stock Exchange (NYSE). This move is expected to provide the company with greater visibility in the market, potentially increasing liquidity and attracting a broader investor base. The uplisting to a more prestigious exchange is often seen as a positive step for companies looking to enhance their reputation and improve access to capital markets.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:35 pm

GOOG

Alphabet Inc (NASDAQ:GOOG) shares dropped after reporting Q4 financial results, despite beating revenue and earnings estimates. Revenue grew 13% to $86.31 billion, and adjusted earnings were $1.64 per share. Google Search, YouTube, and Google Cloud showed strong performance. CEO Sundar Pichai highlighted AI investments and innovation. Alphabet is optimizing its office space and expects higher capital expenditures in 2024. Needham analyst Laura Martin maintained a Buy rating with a $160 price target. Shares fell 4.98% to $145.43.

Portfolio Pulse from Adam Eckert

January 31, 2024 | 1:34 pm

PLSE

Pulse Biosciences has announced preliminary findings from its first-in-human feasibility study of the CellFX nsPFA 360 Cardiac Catheter. The study's results are crucial for the company's progress in developing this technology for cardiac applications.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:31 pm

CRBP

INTC

TCBI

WVE

Insiders at Wave Life Sciences, Corbus Pharmaceuticals, Intel, and Texas Capital Bancshares have made significant stock purchases. GSK plc, a 10% owner of Wave Life Sciences, acquired 3.3 million shares for $16.5 million following an upgrade by Leerink Partners with a $12 price target. Bihua Chen, a 10% owner of Corbus Pharmaceuticals, bought shares worth $9.11 million amid a public offering announcement. Intel's CEO Patrick Gelsinger purchased shares for $130,083 after the company issued lower-than-expected guidance. Robert Stallings, a director at Texas Capital Bancshares, bought shares for $194,890 following disappointing earnings.

Portfolio Pulse from Avi Kapoor

January 31, 2024 | 1:31 pm

SBUX

Starbucks' stock (SBUX) is trading higher following the release of their Q1 financial results, indicating a positive market reaction to the company's performance.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:30 pm

GOOG

GOOGL

Alphabet's stock is trading lower following the release of their Q4 financial results, indicating that the results may have not met investor expectations.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:30 pm